Four California counties filed the lawsuit in 2014, alleging that Allergan, Endo International, Johnson & Johnson and Teva Pharmaceuticals used misleading marketing to increase prescription opioid sales. The drug companies denied any wrongdoing.
The counties were seeking settlements totaling more than $50 billion, which would have supported various public health and drug treatment programs in the state.
In his ruling, Judge Peter Wilson said the plaintiffs failed to provide evidence showing a direct link between drugmakers’ marketing efforts and an increase in illicit use of prescription painkillers.
The ruling marks a significant win for the drug industry, NPR reported, which is facing numerous opioid lawsuits filed by counties, cities and states across the U.S.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
